Schechter Investment Advisors LLC Purchases 50 Shares of Humana Inc. (NYSE:HUM)

Schechter Investment Advisors LLC raised its position in Humana Inc. (NYSE:HUMFree Report) by 10.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 531 shares of the insurance provider’s stock after buying an additional 50 shares during the quarter. Schechter Investment Advisors LLC’s holdings in Humana were worth $258,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in HUM. Sunbelt Securities Inc. bought a new position in Humana in the first quarter valued at approximately $28,000. WFA of San Diego LLC bought a new position in shares of Humana in the 2nd quarter valued at $29,000. Larson Financial Group LLC increased its stake in shares of Humana by 81.0% in the 2nd quarter. Larson Financial Group LLC now owns 76 shares of the insurance provider’s stock valued at $34,000 after purchasing an additional 34 shares during the last quarter. Householder Group Estate & Retirement Specialist LLC acquired a new position in shares of Humana during the 3rd quarter worth $39,000. Finally, Baystate Wealth Management LLC lifted its position in shares of Humana by 84.1% during the 2nd quarter. Baystate Wealth Management LLC now owns 81 shares of the insurance provider’s stock worth $37,000 after buying an additional 37 shares during the last quarter. 91.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts have commented on HUM shares. JPMorgan Chase & Co. lowered their target price on Humana from $593.00 to $575.00 and set a “neutral” rating for the company in a research note on Friday, November 17th. Truist Financial reissued a “hold” rating and set a $550.00 target price on shares of Humana in a research note on Friday, January 19th. UBS Group reissued a “neutral” rating and set a $370.00 target price (down previously from $530.00) on shares of Humana in a research note on Friday, January 26th. Jefferies Financial Group boosted their target price on Humana from $580.00 to $586.00 and gave the stock a “buy” rating in a research note on Monday, October 9th. Finally, Argus raised Humana from a “hold” rating to a “buy” rating and set a $550.00 target price for the company in a research note on Tuesday, December 12th. Seven investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $513.85.

Read Our Latest Stock Report on Humana

Humana Stock Performance

Shares of HUM stock opened at $376.84 on Wednesday. The business’s 50 day simple moving average is $456.19 and its 200 day simple moving average is $475.89. Humana Inc. has a one year low of $342.69 and a one year high of $541.21. The stock has a market capitalization of $46.39 billion, a PE ratio of 19.01, a PEG ratio of 2.15 and a beta of 0.48. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.59 and a quick ratio of 1.37.

Humana (NYSE:HUMGet Free Report) last announced its earnings results on Thursday, January 25th. The insurance provider reported ($0.11) EPS for the quarter, missing the consensus estimate of $0.76 by ($0.87). Humana had a net margin of 2.34% and a return on equity of 19.44%. The company had revenue of $26.46 billion during the quarter, compared to the consensus estimate of $25.47 billion. During the same quarter in the previous year, the company earned $1.62 earnings per share. The business’s revenue was up 17.9% on a year-over-year basis. As a group, research analysts forecast that Humana Inc. will post 16.04 earnings per share for the current year.

About Humana

(Free Report)

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

See Also

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.